Synthetic Biologics Inc (SYN.A)

SYN.A on American Stock Exchange

2.62USD
2 Jul 2015
Change (% chg)

$-0.16 (-5.76%)
Prev Close
$2.78
Open
$2.75
Day's High
$2.75
Day's Low
$2.59
Volume
94,092
Avg. Vol
87,485
52-wk High
$3.22
52-wk Low
$1.32

SYN.A

Chart for SYN.A

About

Synthetic Biologics, Inc. is a clinical-stage biotechnology company. The Company is developing pathogen-specific therapies for serious infections and diseases, with a focus on protecting the microbiome. It is developing an oral biologic to protect the gut microbiome (gastrointestinal (GI) microflora) from intravenous (IV)... (more)

Overall

Beta: 0.92
Market Cap(Mil.): $203.44
Shares Outstanding(Mil.): 73.18
Dividend: --
Yield (%): --

Financials

  SYN.A Industry Sector
P/E (TTM): -- 470.24 39.55
EPS (TTM): -0.42 -- --
ROI: -558.65 -4.50 16.22
ROE: -558.65 -5.38 17.36
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: S&P Capital IQ Quantitative Report
$115.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks